Font Size: a A A
Keyword [model of Parkinson's disease]
Result: 81 - 100 | Page: 5 of 7
81. Effects Of Enriched Environment On BDNF Expression In Midbrain Of The Rat Model Of Parkinson's Disease
82. Effect Of Electroacupuncture On PI3K/Akt Signaling Pathway Of Substantia Nigra In Rat Model Of Parkinson's Disease
83. Effects Of Fasudil On The Behavior Of Of L-DOPA-induced Dyskinesia In A Rat Model Of Parkinson's Disease And The Possible Mechanisms
84. Study On The Protective Effect And Mechanism Of Shanzhiside On The Cell Model Of Parkinson's Disease Based On Molecular Docking
85. Intestinal Pathology And Gut Microbiota In A MPTP Mouse Model Of Parkinson's Disease
86. Short-term Memory Defects And Emotional Changes Following Sleep Deprivation In A Rotenone Treated Zebrafish Model Of Parkinson's Disease
87. Study On The Toxic Effects Of A?1-42 Oligomers And Human A53T Mutant ?-synuclein In Vitro Cell Model Of Parkinson's Disease
88. Resveratrol Rescues Motor And Cognitive Deficits And Neuropathology In A53T ?-synuclein Mouse Model Of Parkinson's Disease
89. The A-type Potassium Channel Blocker 4-AP Protects Nigral Dopaminergic Neurons In The MPTP–induced Mice Model Of Parkinson's Disease
90. The Mechanism And Neuroprotection Of Resveratrol Modulated AMPK-SIRT1 Pathway Deacetylated LC3 In MPTP Mouse Model Of Parkinson's Disease
91. Inhibition Of Glutamine Synthetase Aggravates Neural Impairment In Mouse Model Of Parkinson's Disease Induced By MPTP
92. Effects Of Pramipexole On The Circadian Rhythm Dyfunction In A 6-hydroxydopamine Treated Model Of Parkinson's Disease
93. Effect Of Echinacoside On IRE1?-related Apoptotic Pathway In Rat Model Of Parkinson's Disease
94. Effect Of Electroacupuncture On ATF4/Parkin Signaling Pathway Of Substantia Nnigra In Rat Model Of Parkinson's Disease
95. The Role Of Circadian Clock Gene Bmal1 In A MPTP-Induced Mouse Model Of Parkinson's Disease
96. Neuroprotective Effect And Mechanism Of Catalpol On MPTP Mouse Model Of Parkinson's Disease
97. Research On The Function And Mechanism Of RRS1 In MPP~+-Induced Apoptosis Of SH-SY5Y Cells Model Of Parkinson's Disease
98. Parmipexole Regulates The Depressive-like Symptoms Via Dopamine 3 Receptor In A Mouse Model Of Parkinson's Disease
99. TAT-tagging Exerts Positive Allosteric Modulation Of The PAC1-R And Enhances VIP Neuroprotective Effect In The MPTP Mouse Model Of Parkinson's Disease
100. Therapeutic Effect Of Nasal Administration Of Controlled-Release Icariin Temperature-Sensitive Gel On Mouse Model Of Parkinson's Disease
  <<First  <Prev  Next>  Last>>  Jump to